Daniel J. DeAngelo, MD, PhD

Dana-Farber Cancer Institute

Moderator

Biography

Dr. DeAngelo received his MD and PhD from Albert Einstein College of Medicine in 1993, followed by residency in internal medicine at Massachusetts General Hospital. He served a clinical fellowship in hematology and oncology at the Brigham and Women's Hospital and Dana-Farber Cancer Institute, where he joined the staff in 1999

Financial Disclosure

Amgen, Autolos, Blueprint, Forty-Seven, Gilead, Incyte, Jazz, Novartis, Pfizer, Servier, and Takeda

Consultant

I receive research funding from Abbvie, Novartis and Blueprint Pharmaceuticals

Contractor

I am on the DSMB for Daiichi-Sankyo. Mt Sinai MPN Consortium

Professional Service

Conference History

2026 National Summit on Hematologic Cancers: Defining the Standard Where the Guidelines End

Moderator

2026 National Rare Hematology Summit, Cleveland

Session Chair